Business Segments · Selling, general and administrative expenses
Specialty Diagnostics — Selling, general and administrative expenses
Thermo Fisher Scientific Specialty Diagnostics — Selling, general and administrative expenses decreased by 91.9% to $177M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 91.5%, from $2.08B to $177M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Rolls up toSG&A
How to read this metric
High spending relative to revenue may indicate investment in growth, whereas excessive spending can signal operational bloat.
Detailed definition
Operating expenses incurred by the Specialty Diagnostics segment for non-production activities, including sales force co...
Peer comparison
Benchmarkable against peers to determine the efficiency of the segment's commercial organization.
Metric ID:
tmo_segment_specialty_diagnostics_selling_general_and_administrative_expensesHistorical Data
28 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.9B | $2B | $2.28B | $2.28B | $2.21B | $2.21B | $2.3B | $2.12B | $179M | $2.15B | $179M | $2.05B | $179M | $2.13B | $179M | $2.18B | $2.11B | $2.1B | $178M | $2.2B | $179M | $2.08B | $171M | $183M | $175M | $179M | $2.18B | $177M |
| QoQ Change | — | +5.5% | +13.7% | -0.0% | -3.0% | -0.0% | +4.1% | -7.8% | -91.6% | >999% | -91.7% | >999% | -91.3% | >999% | -91.6% | >999% | -3.3% | -0.6% | -91.5% | >999% | -91.9% | >999% | -91.8% | +7.0% | -4.4% | +2.3% | >999% | -91.9% |
| YoY Change | — | — | — | — | +16.3% | +10.2% | +0.9% | -6.9% | -92.1% | -2.9% | -91.9% | -7.2% | -91.9% | -7.3% | -92.2% | +3.0% | -1.6% | +2.4% | -91.3% | +3.3% | -91.6% | -4.8% | -92.2% | -91.3% | -91.7% | -91.9% | +5.0% | -91.5% |
Range$171M – $2.3B
CAGR-29.6%
Avg YoY Growth-41.6%
Median YoY Growth-7.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — selling, general and administrative expenses of $177M in Q1 2026.
- How has Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses changed year-over-year?
- Thermo Fisher Scientific's specialty diagnostics — selling, general and administrative expenses decreased by 91.5% year-over-year, from $2.08B to $177M.
- What does specialty diagnostics — selling, general and administrative expenses mean?
- The overhead and commercial costs required to run the Specialty Diagnostics segment.